You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Express Scripts
Colorcon
Merck
Mallinckrodt

Last Updated: March 29, 2020

DrugPatentWatch Database Preview

PLAQUENIL Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Plaquenil, and what generic alternatives are available?

Plaquenil is a drug marketed by Concordia and is included in one NDA.

The generic ingredient in PLAQUENIL is hydroxychloroquine sulfate. There are fifteen drug master file entries for this compound. Additional details are available on the hydroxychloroquine sulfate profile page.

Drug patent expirations by year for PLAQUENIL
Drug Prices for PLAQUENIL

See drug prices for PLAQUENIL

Drug Sales Revenue Trends for PLAQUENIL

See drug sales revenues for PLAQUENIL

Recent Clinical Trials for PLAQUENIL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Pediatric Brain Tumor ConsortiumPhase 1/Phase 2
Cures Within ReachPhase 1/Phase 2
University of MichiganPhase 1/Phase 2

See all PLAQUENIL clinical trials

Synonyms for PLAQUENIL
(.+/-.)-Hydroxychloroquine
(+-)-hydroxychloroquine
(+/-)-hydroxychloroquine
118-42-3
118H423
2-((4-((7-Chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol
2-((4-((7-Chloroquinolin-4-yl)amino)pentyl)(ethyl)amino)ethanol
2-((4-(7-chloroquinolin-4-ylamino)pentyl)(ethyl)amino)ethanol
2-({4-[(7-chloro(4-quinolyl))amino]pentyl}ethylamino)ethan-1-ol
2-({4-[(7-chloroquinolin-4-yl)amino]pentyl}(ethyl)amino)ethan-1-ol
2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol
2-[(4-[(7-Chloro-4-quinolinyl)amino]pentyl)(ethyl)amino]ethanol #
2-[[4-[(7-chloroquinolin-4-yl)amino]pentyl](ethyl)amino]ethanol
2-[{4-[(7-Chloroquinolin-4-yl)amino]pentyl}(ethyl)amino]ethan-1-ol
2-[{4-[(7-chloroquinolin-4-yl)amino]pentyl}(ethyl)amino]ethanol
2-[4-[(7-chloro-4-quinolyl)amino]pentyl-ethyl-amino]ethanol
2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol
2-{N-[4-(7-Chloro-4-quinolylamino)pentyl]-N-ethylamino}ethanol
5-22-10-00280 (Beilstein Handbook Reference)
7-Chloro-4-(4-(ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline
7-Chloro-4-(4-(N-ethyl-N-.beta.-hydroxyethylamino)-1-methylbutylamino)quinoline
7-Chloro-4-(4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline
7-Chloro-4-(5-(N-ethyl-N-2-hydroxyethylamino)-2-pentyl)aminoquinoline
7-chloro-4-[4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline
7-chloro-4-[4-[ethyl(2-hydroxyethyl)amino]1-methylbutylamino]-quinoline
7-chloro-4-[4-[ethyl(2-hydroxyethyl)amino]1-methylbutylamino]quinoline
7-chloro-4-[5-(N-ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline
AB00053257_02
AKOS015997886
ALBB-022466
BRD-A99117172-065-01-6
BRD-A99117172-065-02-4
BRN 0253894
C07043
C18H26ClN3O
CC-29437
CCG-208059
CHEBI:5801
CHEMBL1535
D08050
DB01611
DivK1c_000942
Dolquine
DTXSID8023135
EINECS 204-249-8
Ercoquin (Salt/Mix)
Ethanol, 2-((4-((7-chloro-4-quinolinyl)amino)pentyl)ethylamino)-
Ethanol, 2-((4-((7-chloro-4-quinolyl)amino)pentyl)ethylamino)-
Ethanol, 2-[[4-[(7-chloro-4-quinolinyl)amino]pentyl]ethylamino]-
Ethanol, 2-[[4-[(7-chloro-4-quinolinyl)amino]pentyl]ethylamino]-, sulfate (1:1)
Ethanol, 2-[[4-[(7-chloro-4-quinolyl)amino]pentyl]ethylamino]-
F2173-0553
FT-0627143
GTPL7198
HCQ
Hidroxicloroquina
Hidroxicloroquina [INN-Spanish]
HMS502P04
HYDROXY CHLOROQUINE
Hydroxychlorochin
hydroxychloroquine
Hydroxychloroquine (INN)
Hydroxychloroquine [INN:BAN]
Hydroxychloroquine Sulfate (1:1) Salt
Hydroxychloroquinum
Hydroxychloroquinum [INN-Latin]
IDI1_000942
Idrossiclorochina
Idrossiclorochina [DCIT]
KBio1_000942
LS-66614
M566
MCULE-6282304706
NCGC00159483-02
NCGC00159483-03
NCGC00159483-06
NINDS_000942
NSC4375
oxichlorochine
Oxichlorochinum
Oxichloroquine
Oxychlorochin
Oxychloroquine
Polirreumin
Polirreumin (TN)
Q421094
Quensyl
SBB012559
SBI-0052759.P002
SCHEMBL8170
SPBio_001116
Spectrum2_001238
Spectrum5_001697
ST072188
STL429829
VZ36170
WIN 1258
Win 1258-2
XXSMGPRMXLTPCZ-UHFFFAOYSA-N
ZX-AN038051

US Patents and Regulatory Information for PLAQUENIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Concordia PLAQUENIL hydroxychloroquine sulfate TABLET;ORAL 009768-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Express Scripts
Colorcon
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.